kauran-16-ol | 63949-94-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: kauran-16-ol
• 英文别名: (1R,4S,9S,10S,13S,14S)-5,5,9,14-tetramethyltetracyclo[11.2.1.01,10.04,9]hexadecan-14-ol
• CAS: 63949-94-0
• 化学式: C₂₀H₃₄O
• 分子量: 290.489
• InChiKey: FZSRMADKTOBCNT-JFVPRCSHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• TISSUE DEGENERATION PROTECTION
  申请人：Geuns Joannes

  公开号：US20100099640A1

  公开（公告）日：2010-04-22

  The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutically acceptable salts of the same for use of such compounds or compositions in a treatment of cardiovascular disorders or vascular disease or for the manufacture of medicaments to treat a condition of a cardiovascular disorder or vascular disease.

  本发明提供了分离或基本纯的二萜四氢吡喃类化合物，例如甜菊糖苷-19-葡萄糖醛酸酯，甜菊糖，甜菊糖苷和葛根糖苷，以及获得它们的方法和获得这些化合物的稳定的药学上可接受的盐的方法，用于治疗心血管疾病或血管疾病或用于制造治疗心血管疾病或血管疾病症状的药物。
• Heterologous production of patchoulol, β-santalene, and sclareol in moss cells
  申请人：UNIVERSITY OF COPENHAGEN

  公开号：US10053703B2

  公开（公告）日：2018-08-21

  The present invention relates to methods for preparing patchoulol, β-santalene, and sclareol in transgenic moss cells that include heterologous nucleic acid molecules encoding a polypeptide or synthase capable of using FPP or GGPP as a substrate. Methods for producing the transgenic moss cell, as well as the transgenic moss cell itself are also disclosed.

  本发明涉及在转基因苔藓细胞中制备斑蝥酚、β-山茶烯和香紫苏醇的方法，转基因苔藓细胞包括编码能够使用 FPP 或 GGPP 作为底物的多肽或合成酶的异源核酸分子。此外，还公开了生产转基因苔藓细胞以及转基因苔藓细胞本身的方法。
• SYSTEMS FOR PEST ELIMINATION, SUPPRESSION OR CONTROL
  申请人：Emekatech, LLC

  公开号：EP3110253A1

  公开（公告）日：2017-01-04
• TRANSGENIC MOSS PRODUCING TERPENOIDS
  申请人：Anterola Aldwin Macaraig

  公开号：US20100297722A1

  公开（公告）日：2010-11-25

  The present invention generally relates to transgenic moss. One aspect of the invention provides a transgenic moss cell that produces or accumulates a terpenoid compound. Another aspect of the invention provides for methods of producing a terpenoid compound through culturing of the transgenic moss.
• HETEROLOGOUS PRODUCTION OF PATCHOULOL, BETA-SANTALENE, AND SCLAREOL IN MOSS CELLS
  申请人：KØBENHAVNS UNIVERSITET

  公开号：US20160222401A1

  公开（公告）日：2016-08-04

  The present invention relates to methods for preparing patchoulol, β-santalene, and sclareol in transgenic moss cells that include heterologous nucleic acid molecules encoding a polypeptide or synthase capable of using FPP or GGPP as a substrate. Methods for producing the transgenic moss cell, as well as the transgenic moss cell itself are also disclosed.